Search Contract Opportunities

RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for PrEP

ID: RPP-24-03-PrEP • Type: Special Notice • Match:  100%
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Popular Questions:

Description

This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA), titled, COVID-19 Monoclonal Antibody Therapeutics for PrEP".

The full RPP as well as information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.

Show All

Overview

Agency
HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) [HHS]
Response Deadline
Jan. 19, 2024, 3:00 p.m. EST Past Due
Posted
Dec. 1, 2023, 3:47 p.m. EST
Set Aside
None
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN42 - Health R&D Services; Health Care - Other; Applied Research
Place of Performance
Not Provided
Source
Open
Current SBA Size Standard
1000 Employees
Pricing
Multiple Types Common
On 12/1/23 HHS Office of the Assistant Secretary for Preparedness and Response issued Special Notice RPP-24-03-PrEP for RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for PrEP due 1/19/24.
Primary Contact
Name
Rebecca Harmon   Profile
Email
rebecca.harmon@ati.org
Phone
None

Documents

Posted documents for Special Notice RPP-24-03-PrEP

Opportunity Assistant

AI Analysis

Incumbent or Similar Awards

Contracts Similar to Special Notice RPP-24-03-PrEP

Potential Bidders and Partners

Awardees that have won contracts similar to Special Notice RPP-24-03-PrEP

Similar Active Opportunities

Open contract opportunities similar to Special Notice RPP-24-03-PrEP

Experts for RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for PrEP

Recommended subject matter experts available for hire

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE > BARDA - ASPR / DAAPPO / BARDA DCMA
FPDS Organization Code
7505-00100
Source Organization Code
100188027
Last Updated
Feb. 3, 2024
Last Updated By
caleb.owen@hhs.gov
Archive Date
Feb. 3, 2024